Delivery Order SPE2DB22D3004-SPE2DB24FQD28
Award Date 4/25/24
Potential Completion Date 4/26/24
Potential Value $5.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,112.67, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order against an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of...
- This federal contract award, valued at $1,972.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of May 2, 2023 and is a Firm Fixed Price Delivery Order contract. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $4,415.57 for REXULTI 1 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating full and open competition. The contract is a task order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $3,892.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product REXULTI 0.5 MG TABLET 30S. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award, valued at $20,117.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of the pharmaceutical product REXULTI 1 MG TABLET 30S. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award, with the ID SPE2DX15D2003|SPE2DX24F4ZZ2, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,562.40 firm fixed-price delivery order is for the supply of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 11, 2024 and was awarded on January 10, 2024 without any set-aside designation. Amerisourcebergen Drug Corp holds a...
- This federal contract award, with identification number SPE2DX15D3017|SPE2DX24F0JAX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of REXULTI 3 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $12,918.22. This is a firm fixed-price delivery order contract with a period of performance ending on November 2, 2023. The contract is not designated as a set-aside and...
- This federal contract award, valued at $13,956.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 4563218543 - REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 4, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract, valued at $2,656.05, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,545.77, is for the delivery of REXULTI 1 MG TABLET 30S, a prescription medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQD28Delivery Order
This federal contract award, valued at $5,621.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has a firm fixed price pricing type and an ultimate completion date of April 26, 2024. There is no set-aside designation associated with this award.
Generated 5/16/25, 12:36 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 4/25/24 |